Although a normal cell line was not included in the study for comparison, numerous studies, both in vivo and even clinical trials, have established that PLK1 inhibition by siRNA or BI 2536 is well tolerated, with neutropenia being the main side effect [26,28,39,47-49]. Here, PLK1 is linked to Decreased total neutrophil count.